Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -69.32 Million CAD | 73.72% |
| 2022 | -263.78 Million CAD | 84.64% |
| 2021 | -1.71 Billion CAD | -147.63% |
| 2020 | -693.62 Million CAD | 79.05% |
| 2019 | -3.31 Billion CAD | -1038.21% |
| 2018 | -290.83 Million CAD | -504.3% |
| 2017 | 71.93 Million CAD | 654.72% |
| 2016 | -12.96 Million CAD | -126.57% |
| 2015 | -5.72 Million CAD | 39.87% |
| 2014 | -9.51 Million CAD | -2281.35% |
| 2013 | -399.7 Thousand CAD | -1.58% |
| 2012 | -393.48 Thousand CAD | -24.62% |
| 2011 | -315.76 Thousand CAD | 2.09% |
| 2010 | -322.49 Thousand CAD | -634.52% |
| 2009 | -43.9 Thousand CAD | 69.86% |
| 2008 | -145.65 Thousand CAD | 17.84% |
| 2007 | -177.28 Thousand CAD | -14092.58% |
| 2006 | 1267.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q3 | -17.4 Million CAD | 28.95% |
| 2023 Q1 | -2.12 Million CAD | 92.49% |
| 2023 FY | -69.32 Million CAD | 73.72% |
| 2023 Q2 | -24.49 Million CAD | -1051.81% |
| 2022 FY | -263.78 Million CAD | 84.64% |
| 2022 Q4 | -28.33 Million CAD | -106.02% |
| 2022 Q2 | -65.39 Million CAD | -26.72% |
| 2022 Q1 | -51.6 Million CAD | 91.66% |
| 2022 Q3 | 470.45 Million CAD | 819.44% |
| 2021 Q4 | -618.42 Million CAD | 38.9% |
| 2021 Q3 | -1.01 Billion CAD | -1247.0% |
| 2021 Q1 | -11.88 Million CAD | 90.72% |
| 2021 Q2 | -75.14 Million CAD | -532.3% |
| 2021 FY | -1.71 Billion CAD | -147.63% |
| 2020 Q1 | -108.06 Million CAD | 94.31% |
| 2020 Q2 | -292.78 Million CAD | -170.94% |
| 2020 Q3 | -164.65 Million CAD | 43.76% |
| 2020 Q4 | -128.12 Million CAD | 22.18% |
| 2020 FY | -693.62 Million CAD | 79.05% |
| 2019 FY | -3.31 Billion CAD | -1038.21% |
| 2019 Q4 | -1.89 Billion CAD | -1282.56% |
| 2019 Q3 | -137.39 Million CAD | 89.32% |
| 2019 Q2 | -1.28 Billion CAD | -10182.54% |
| 2019 Q1 | 12.75 Million CAD | 6709.33% |
| 2018 Q4 | -193 Thousand CAD | 99.88% |
| 2018 FY | -290.83 Million CAD | -504.3% |
| 2018 Q3 | -158.35 Million CAD | 33.4% |
| 2018 Q2 | -237.75 Million CAD | -325.44% |
| 2018 Q1 | 105.46 Million CAD | 32.04% |
| 2017 FY | 71.93 Million CAD | 654.72% |
| 2017 Q4 | 79.86 Million CAD | 515.66% |
| 2017 Q3 | -19.21 Million CAD | -348.87% |
| 2017 Q2 | 7.72 Million CAD | 116.88% |
| 2017 Q1 | 3.56 Million CAD | 173.92% |
| 2016 Q1 | -5.61 Million CAD | 24.9% |
| 2016 Q2 | -2.67 Million CAD | 52.29% |
| 2016 Q3 | 138.83 Thousand CAD | 105.18% |
| 2016 Q4 | -4.81 Million CAD | -3569.05% |
| 2016 FY | -12.96 Million CAD | -126.57% |
| 2015 Q1 | -1.36 Million CAD | -104.68% |
| 2015 Q3 | 2.52 Million CAD | 326.16% |
| 2015 Q2 | 592.92 Thousand CAD | 143.31% |
| 2015 Q4 | -7.47 Million CAD | -395.79% |
| 2015 FY | -5.72 Million CAD | 39.87% |
| 2014 Q2 | -6.25 Million CAD | -1130.12% |
| 2014 Q4 | 29.24 Million CAD | 3882.85% |
| 2014 Q3 | -773.17 Thousand CAD | 87.63% |
| 2014 Q1 | -508.29 Thousand CAD | -113.66% |
| 2014 FY | -9.51 Million CAD | -2281.35% |
| 2013 FY | -399.7 Thousand CAD | -1.58% |
| 2013 Q2 | -29.1 Thousand CAD | 26.78% |
| 2013 Q3 | -92.96 Thousand CAD | -219.46% |
| 2013 Q4 | -237.89 Thousand CAD | -155.91% |
| 2013 Q1 | -39.74 Thousand CAD | 62.3% |
| 2012 Q1 | -148.91 Thousand CAD | 24.85% |
| 2012 Q3 | -73.05 Thousand CAD | -7.27% |
| 2012 FY | -393.48 Thousand CAD | -24.62% |
| 2012 Q2 | -68.1 Thousand CAD | 54.27% |
| 2012 Q4 | -105.41 Thousand CAD | -44.3% |
| 2011 Q1 | -40.83 Thousand CAD | 25.43% |
| 2011 Q4 | -198.16 Thousand CAD | -375.91% |
| 2011 FY | -315.76 Thousand CAD | 2.09% |
| 2011 Q2 | -35.12 Thousand CAD | 13.97% |
| 2011 Q3 | -41.63 Thousand CAD | -18.54% |
| 2010 Q4 | -54.75 Thousand CAD | 75.21% |
| 2010 Q1 | -34.29 Thousand CAD | 28.27% |
| 2010 Q2 | -12.61 Thousand CAD | 63.21% |
| 2010 FY | -322.49 Thousand CAD | -634.52% |
| 2010 Q3 | -220.83 Thousand CAD | -1650.28% |
| 2009 FY | -43.9 Thousand CAD | 69.86% |
| 2009 Q4 | -47.8 Thousand CAD | -80.56% |
| 2009 Q3 | -26.47 Thousand CAD | -159.69% |
| 2009 Q2 | -10.19 Thousand CAD | 43.12% |
| 2009 Q1 | -17.92 Thousand CAD | -1.86% |
| 2008 Q4 | -17.59 Thousand CAD | 40.65% |
| 2008 Q2 | -22.31 Thousand CAD | 70.67% |
| 2008 FY | -145.65 Thousand CAD | 17.84% |
| 2008 Q3 | -29.64 Thousand CAD | -32.84% |
| 2008 Q1 | -76.09 Thousand CAD | -238.8% |
| 2007 Q3 | -4675.00 CAD | 96.89% |
| 2007 Q1 | 204.00 CAD | 0.0% |
| 2007 Q4 | -22.46 Thousand CAD | -380.43% |
| 2007 Q2 | -150.35 Thousand CAD | -73803.43% |
| 2007 FY | -177.28 Thousand CAD | -14092.58% |
| 2006 FY | 1267.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Avicanna Inc. | -8.74 Million CAD | -692.931% |
| Avant Brands Inc. | -5.07 Million CAD | -1267.377% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | -146.464% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -3390.735% |
| Knight Therapeutics Inc. | -16.83 Million CAD | -311.797% |
| MediPharm Labs Corp. | -13.08 Million CAD | -429.894% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 69.79% |
| Canopy Growth Corporation | -657.26 Million CAD | 89.452% |
| Willow Biosciences Inc. | -13.02 Million CAD | -432.09% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | -55.75% |